NCT04176367View on ClinicalTrials.gov

An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

September 29, 2020

Study Completion Date

September 29, 2020

Conditions
Pharmacokinetics
Interventions
DRUG

Nicergoline from China

This is the test arm of China local manufactured Nicergoline

DRUG

Nicergoline from Italy

This is the reference arm of Italy originator Nicergoline.

Trial Locations (1)

102200

Beijing Hospital, Beijing

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT04176367 - An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants | Biotech Hunter | Biotech Hunter